Results - Announcements
Solara Active Pharma Sciences Ltd share price inched up 1.92% to Rs 652.8 after the company's net profit soared by 74.49% to Rs 28.46 crore, while revenue from operations slightly gained 9.37% to Rs 417.34 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 26.82 lakh crore, gaining 4.13%. It has softened by 0.63% over last one week and crept higher by 0.66% in last one month while the market capitalization of Solara Active Pharma Sciences Ltd has marginally improved by 1.16% and 16.14% in the same period respectively.
Profit before tax (PBT) of Solara Active Pharma Sciences Ltd stood at Rs 28.46 crore in Q3 FY26, crashing by 381.78% year-on-year, and rallying 74.49% quarter-on-quarter. EBITDA came in at Rs 76 crore, surging by 122.84% YoY and jumping 28.71% sequentially.
Total expenses grew marginally by 6.01% to Rs 367.14 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 217.8 crore, witnessing a sharp rise of 20.46% YoY, while employee benefits expense was at Rs 57.62 crore, inching up 2.80% YoY.
For the TTM ended FY26, revenue from operations inched higher 6.64% to Rs 1368.98 crore, while net profit tumbled by 1472.22% to Rs 7.41 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 19739% to Rs 180.59 crore, and PBT collapsed by 1472.22% to Rs 7.41 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 152.91 crore in FY26, as against Rs 212.82 crore in FY25.
Solara Active Pharma Sciences Ltd rallied 12.54% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 10.04% during the same period.